Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

JT Jensen - Expert opinion on pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Since ethinyl estradiol is a potent activator of hepatic enzymes, the
use of natural estradiol (E2) has been studied; but, until recently, bleeding control has …

Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding

E Micks, JT Jensen - Women's Health, 2011 - journals.sagepub.com
Estradiol valerate and dienogest have been combined to create a novel four-phasic oral
contraceptive pill effective for both pregnancy prevention and treatment of heavy menstrual …

Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America …

A Nelson, S Parke, D Makalova, M Serrani… - … European Journal of …, 2013 - Taylor & Francis
Objective To summarise all clinical data on the contraceptive efficacy and bleeding profile
associated with an oestradiol valerate (E2V) and dienogest (DNG)[E2V/DNG] combined oral …

Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest

S Rafie, L Borgelt, ER Koepf… - … Journal of Women's …, 2013 - Taylor & Francis
Abnormal uterine bleeding (AUB) is associated with significant direct medical costs and
impacts both society and the quality of life for individual women. Heavy menstrual bleeding …

Estradiol valerate and dienogest: a new approach to oral contraception

JW Kiley, LP Shulman - International journal of women's health, 2011 - Taylor & Francis
Most combination oral contraceptives contain ethinyl estradiol and a progestin. A new and
novel oral contraceptive formulation combines estradiol valerate (E2V) with dienogest …

Estradiol valerate/dienogest: a novel combined oral contraceptive

LM Borgelt, CW Martell - Clinical therapeutics, 2012 - Elsevier
BACKGROUND: Estradiol valerate/dienogest (E2V/DNG) is a combined oral contraceptive
(COC) with 2 new hormonal entities and a unique 4-phasic dosing regimen indicated for …

Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America

A Nelson, S Parke, U Mellinger… - Journal of Women's …, 2014 - liebertpub.com
Background: This study investigated the efficacy and safety of a combined oral contraceptive
(COC) containing estradiol valerate/dienogest (E2V/DNG). Methods: This was a multicenter …

Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill

EA Micks, JT Jensen - Advances in therapy, 2013 - Springer
The new estradiol valerate and dienogest oral contraceptive pill recently received US Food
and Drug Administration (FDA) approval to treat heavy menstrual bleeding in women without …

Estradiol valerate/dienogest: a novel oral contraceptive

KL Whalen, R Rose - Annals of Pharmacotherapy, 2011 - journals.sagepub.com
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the new
oral contraceptive estradiol valerate/dienogest. Data Sources: Searches of PubMed (1966 …

Estradiol valerate/dienogest: in oral contraception

SM Hoy, LJ Scott - Drugs, 2009 - Springer
Abstract▴ Estradiol valerate/dienogest is an oral contraceptive for women that combines the
natural estrogen estradiol with the 19-nortestosterone derivative dienogest in a four-phasic …